This activity is supported by an educational donation provided by Amgen.
Osteoporosis Compendium
  1. Course List

Currently Available

Course Title Faculty Release Date
Monitoring—Chapter (6) 1892.06 Lewiecki Feb 2010
Management of the Postfracture Patient—Chapter (5) 1892.05 Lambing Jan 2010
Expert Insight Into: Efficacy and Safety of Balloon Kyphoplasty Compared with Nonsurgical Care for Vertebral Compression Fracture: A Randomized Controlled Trial—Article Review (OC01.26) 1898.12 Lambing Jan 2010
Expert Insight Into: Vitamin D Deficiency is Associated with Worse Cognitive Performance and Lower Bone Density in Older African Americans—Article Review (OC01.25) 1898.11 Lewiecki Dec 2009
Treatment of Osteoporosis—Chapter (4) 1892.04 Nieves
Miller		 Dec 2009
Expert Insight Into: IV Bisphosphonate Therapy and Clinical Fractures and Mortality After Hip Fracture—Article Review (OC01.23) 1898.09 Lambing Dec 2009
Case Study: Management of Poor Response to Bisphosphonate Therapy—Tx Reporter e-Newsletter (OC01.22) 1894.04 Lewiecki Nov 2009
Selecting Pharmacologic Therapy —Audio Interview (OC01.21) 1895.03 Lewiecki
Lambing		 Nov 2009
Expert Insight Into: Skeletal Effects of Serotonin Reuptake Inhibitors: Evidence from Clinical Studies—Article Review (OC01.20) 1898.10 Lewiecki Nov 2009
Assessment of Fracture Risk Using FRAX®—Chapter (3) 1892.03 Luckey Nov 2009
Expert Insight Into: Secondary Contributors to Bone Loss in Osteoporosis Related Hip Fractures—Article Review (OC01.18) 1898.08 Luckey Oct 2009
Case Study: Preserving Bone Health in a Patient with COPD on Corticosteroid Therapy—Tx Reporter e-Newsletter (OC01.17) 1894.03 Luckey Oct 2009
Clinical Insights Based on Proceedings from the ASBMR 31st Annual Meeting—Meeting Analysis (OC01.16) 1896.02 Luckey
Lewiecki		 Oct 2009
Expert Insight Into: Novel Therapy in Prevention of Fractures in Postmenopausal Women with Osteoporosis—Article Review (OC01.15) 1898.07 Siris Sep 2009
Expert Insight Into: Implications of Absolute Fracture Risk Assessment for Osteoporosis Practice Guidelines in the USA—Article Review (OC01.14) 1898.06 Siris Aug 2009
Physician's Role in Addressing Bone Health Before Menopause—Audio Interview (OC01.13) 1895.02 Levine
Bachmann		 Aug 2009
Case Study: Assessment and Management of Osteoporosis Secondary to Androgen Deprivation Therapy in Prostate Cancer—Tx Reporter e-Newsletter (OC01.12) 1894.02 Levine
Siris
Lambing		 Jul 2009
Identifying Patients at Risk for Osteoporosis and Fractures—Chapter (2) 1892.02 Luckey Jul 2009
Expert Insight Into: Serum 25-Hydroxyvitamin D and Hip Fracture Risk in Older US White Adults—Article Review (OC01.10) 1898.05 Bachmann Jul 2009
Hot Topics and Controversies in Osteoporosis Management—Webcast (OC01.09) 1893 Levine
Siris
Luckey		 Jul 2009
Expert Insight Into: Integrated Analysis of Bisphosphonate Therapy for Prevention of Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole—Article Review (OC01.08) 1898.04 Levine Jul 2009
Case Study: Use of FRAX® and Strategies for Management of Increased Fracture Risk in Postmenopausal Women with Osteopenia—Tx Reporter e-Newsletter (OC01.07) 1894.01 Siris Jun 2009
Overview of Osteoporosis—Chapter (1) 1892.01 Lewiecki May 2009
Expert Insight Into: Assessing the Clinical Utility of Serum CTX in Postmenopausal Osteoporosis and Its Use in Predicting Risk of Osteonecrosis of the Jaw—Article Review (OC01.05) 1898.03 Lewiecki May 2009
Assessment and Primary Prevention of Osteoporosis and Fractures—Audio Interview (OC01.04) 1895.01 Levine
Siris		 Apr 2009
Expert Insight Into: Benefit of Adherence with Bisphosphonates Depends on Age and Fracture Type: Results from an Analysis of 101,038 New Bisphosphonate Users—Article Review (OC01.02) 1898.02 Levine Apr 2009
Expert Insight Into: Long-Term Mortality Associated with Low-Trauma Osteoporotic Fracture and Risk of Subsequent Fracture—Article Review (OC01.01) 1898.01 Luckey Mar 2009